• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Management of Parkinson Disease in 2017: Personalized Approaches for Patient-Specific Needs.

作者信息

Okun Michael S

机构信息

Departments of Neurology and Neurosurgery, University of Florida Center for Movement Disorders and Neurorestoration, Gainesville.

出版信息

JAMA. 2017 Sep 5;318(9):791-792. doi: 10.1001/jama.2017.7914.

DOI:10.1001/jama.2017.7914
PMID:28828469
Abstract
摘要

相似文献

1
Management of Parkinson Disease in 2017: Personalized Approaches for Patient-Specific Needs.2017年帕金森病的管理：针对患者特定需求的个性化方法。
JAMA. 2017 Sep 5;318(9):791-792. doi: 10.1001/jama.2017.7914.
2
New and emerging treatments for Parkinson disease.帕金森病的新型及新兴治疗方法。
Med J Aust. 2015 Apr 6;202(6):283-4. doi: 10.5694/mja15.00155.
3
[New methods in the pharmacotherapy of Parkinson disease].帕金森病药物治疗的新方法
Nervenarzt. 1996 Nov;67(11 Suppl Neue Strat):1-8.
4
Parkinson's disease: recent development in therapies for advanced disease with a focus on deep brain stimulation (DBS) and duodenal levodopa infusion.帕金森病：晚期疾病治疗的最新进展，重点关注深部脑刺激（DBS）和十二指肠左旋多巴输注。
FEBS J. 2008 Apr;275(7):1370-1376. doi: 10.1111/j.1742-4658.2008.06295.x. Epub 2008 Feb 12.
5
Can we achieve neuroprotection with currently available anti-parkinsonian interventions?我们能否通过目前可用的抗帕金森病干预措施实现神经保护？
Neurology. 2009 Feb 17;72(7 Suppl):S59-64. doi: 10.1212/WNL.0b013e318199068b.
6
[Update on Current Care Guideline: Parkinson's disease].[当前护理指南更新：帕金森病]
Duodecim. 2016;132(1):91-3.
7
Inhibitors of dopamine inactivating systems as antiparkinson drugs.作为抗帕金森病药物的多巴胺失活系统抑制剂。
Adv Neurol. 1990;53:483-8.
8
[Revision of the treatment strategy in Parkinson disease].[帕金森病治疗策略的修订]
Ned Tijdschr Geneeskd. 1986 May 17;130(20):914-8.
9
ADAGIO misses a beat?阿第吉奥（ADAGIO）慢了一拍？
Lancet Neurol. 2009 Dec;8(12):1081-2. doi: 10.1016/S1474-4422(09)70297-2.
10
[Pharmacological treatment of parkinsonism].[帕金森综合征的药物治疗]
Neurol Neurochir Pol. 1977 Nov-Dec;11(6):689-93.

引用本文的文献

1
Effects of tele-rehabilitation after deep brain stimulation on cardiopulmonary fitness and gait in patients with Parkinson's disease.帕金森病患者深部脑刺激术后远程康复对心肺适能和步态的影响
Neurol Sci. 2025 May 23. doi: 10.1007/s10072-025-08222-7.
2
Satisfaction, effectiveness, and usability of telerehabilitation for Parkinson's disease patients.帕金森病患者远程康复的满意度、有效性和可用性。
J Rehabil Med. 2025 Jan 3;57:jrm39819. doi: 10.2340/jrm.v57.39819.
3
Efficacy of acupuncture (Jin's three-needle) on motor symptoms and anxiety in patients with Parkinson's disease: protocol for a multicentre, randomised, assessor-blinded clinical trial.
针灸（靳三针）治疗帕金森病患者运动症状和焦虑的疗效：一项多中心、随机、评估者盲法临床试验方案。
BMJ Open. 2024 Mar 28;14(3):e081312. doi: 10.1136/bmjopen-2023-081312.
4
Balancing feeling 'prepared' without feeling 'devoured': A qualitative study of self-care from the perspective of self-empowered persons living with Parkinson's disease in Sweden.平衡“有准备”的感觉而不感到“被吞噬”：瑞典自感有能力的帕金森病患者的自我护理的定性研究。
Health Expect. 2024 Apr;27(2):e14027. doi: 10.1111/hex.14027.
5
The Levels and Associated Factors for Participation and Autonomy Among People with Parkinson´s Disease: A Cross-Sectional Study.帕金森病患者参与度和自主性的水平及其相关因素：一项横断面研究。
Psychol Res Behav Manag. 2024 Mar 12;17:1045-1055. doi: 10.2147/PRBM.S448240. eCollection 2024.
6
Physical activities and risk of neurodegenerative diseases: A two-sample Mendelian randomization study.身体活动与神经退行性疾病风险：一项两样本孟德尔随机化研究。
Front Aging Neurosci. 2022 Sep 23;14:991140. doi: 10.3389/fnagi.2022.991140. eCollection 2022.
7
Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease: Past, Present, and Future.单胺氧化酶-B 抑制剂治疗帕金森病：过去、现在和未来。
J Parkinsons Dis. 2022;12(2):477-493. doi: 10.3233/JPD-212976.
8
An Update on the Critical Role of α-Synuclein in Parkinson's Disease and Other Synucleinopathies: from Tissue to Cellular and Molecular Levels.α-突触核蛋白在帕金森病和其他突触核蛋白病中的关键作用的最新研究进展：从组织到细胞和分子水平。
Mol Neurobiol. 2022 Jan;59(1):620-642. doi: 10.1007/s12035-021-02596-3. Epub 2021 Nov 8.
9
Transgenic Mice Expressing Human α-Synuclein 1-103 Fragment as a Novel Model of Parkinson's Disease.表达人α-突触核蛋白1-103片段的转基因小鼠作为帕金森病的新型模型
Front Aging Neurosci. 2021 Oct 22;13:760781. doi: 10.3389/fnagi.2021.760781. eCollection 2021.
10
Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson's Disease.以患者为中心确定用于治疗帕金森病的医疗器械的有意义的监管终点
MDM Policy Pract. 2021 Jul 2;6(1):23814683211021380. doi: 10.1177/23814683211021380. eCollection 2021 Jan-Jun.